Literature DB >> 21059651

The inhibition mechanism of non-phosphorylated Ser768 in the regulatory domain of cystic fibrosis transmembrane conductance regulator.

Guangyu Wang1.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a member of the ATP-binding cassette transporters but serves as a chloride channel dysfunctional in cystic fibrosis. The activity of CFTR is tightly controlled not only by ATP-driven dimerization of its nucleotide-binding domains but also by phosphorylation of a unique regulatory (R) domain by protein kinase A (PKA). The R domain has multiple excitatory phosphorylation sites, but Ser(737) and Ser(768) are inhibitory. The underlying mechanism is unclear. Here, sulfhydryl-specific cross-linking strategy was employed to demonstrate that Ser(768) or Ser(737) could interact with outwardly facing hydrophilic residues of cytoplasmic loop 3 regulating channel gating. Furthermore, mutation of these residues to alanines promoted channel opening by curcumin in an ATP-dependent manner even in the absence of PKA. However, mutation of Ser(768) and His(950) with different hydrogen bond donors or acceptors clearly changed ATP- and PKA-dependent channel activity no matter whether curcumin was present or not. More importantly, significant activation of a double mutant H950R/S768R needed only ATP. Finally, in vitro and in vivo single channel recordings suggest that Ser(768) may form a putative hydrogen bond with His(950) of cytoplasmic loop 3 to prevent channel opening by ATP in the non-phosphorylated state and by subsequent cAMP-dependent phosphorylation. These observations support an electron cryomicroscopy-based structural model on which the R domain is closed to cytoplasmic loops regulating channel gating.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059651      PMCID: PMC3023513          DOI: 10.1074/jbc.M110.145540

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  CFTR activation: additive effects of stimulatory and inhibitory phosphorylation sites in the R domain.

Authors:  D J Wilkinson; T V Strong; M K Mansoura; D L Wood; S S Smith; F S Collins; D C Dawson
Journal:  Am J Physiol       Date:  1997-07

2.  Covalent modification of the regulatory domain irreversibly stimulates cystic fibrosis transmembrane conductance regulator.

Authors:  J F Cotten; M J Welsh
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

3.  Structure of a bacterial multidrug ABC transporter.

Authors:  Roger J P Dawson; Kaspar P Locher
Journal:  Nature       Date:  2006-08-30       Impact factor: 49.962

4.  CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains.

Authors:  Paola Vergani; Steve W Lockless; Angus C Nairn; David C Gadsby
Journal:  Nature       Date:  2005-02-24       Impact factor: 49.962

5.  Phosphorylation of the R domain by cAMP-dependent protein kinase regulates the CFTR chloride channel.

Authors:  S H Cheng; D P Rich; J Marshall; R J Gregory; M J Welsh; A E Smith
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

6.  CFTR chloride channel regulation by an interdomain interaction.

Authors:  A P Naren; E Cormet-Boyaka; J Fu; M Villain; J E Blalock; M W Quick; K L Kirk
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

7.  State-dependent regulation of cystic fibrosis transmembrane conductance regulator (CFTR) gating by a high affinity Fe3+ bridge between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang
Journal:  J Biol Chem       Date:  2010-10-15       Impact factor: 5.157

8.  Phosphorylation by cAMP-dependent protein kinase causes a conformational change in the R domain of the cystic fibrosis transmembrane conductance regulator.

Authors:  A M Dulhanty; J R Riordan
Journal:  Biochemistry       Date:  1994-04-05       Impact factor: 3.162

9.  In vivo phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer.

Authors:  Martin Mense; Paola Vergani; Dennis M White; Gal Altberg; Angus C Nairn; David C Gadsby
Journal:  EMBO J       Date:  2006-10-12       Impact factor: 11.598

10.  Preferential phosphorylation of R-domain Serine 768 dampens activation of CFTR channels by PKA.

Authors:  László Csanády; Donna Seto-Young; Kim W Chan; Cristina Cenciarelli; Benjamin B Angel; Jun Qin; Derek T McLachlin; Andrew N Krutchinsky; Brian T Chait; Angus C Nairn; David C Gadsby
Journal:  J Gen Physiol       Date:  2005-01-18       Impact factor: 4.086

View more
  5 in total

Review 1.  Mechanistic insight into the heme-independent interplay between iron and carbon monoxide in CFTR and Slo1 BKCa channels.

Authors:  Guangyu Wang
Journal:  Metallomics       Date:  2017-05-05       Impact factor: 4.526

2.  CLC anion channel regulatory phosphorylation and conserved signal transduction domains.

Authors:  Hiroaki Miyazaki; Toshiki Yamada; Angela Parton; Rebecca Morrison; Sunghoon Kim; Albert H Beth; Kevin Strange
Journal:  Biophys J       Date:  2012-10-16       Impact factor: 4.033

3.  Protein kinase A phosphorylation potentiates cystic fibrosis transmembrane conductance regulator gating by relieving autoinhibition on the stimulatory C terminus of the regulatory domain.

Authors:  Jeng-Haur Chen
Journal:  J Biol Chem       Date:  2020-02-26       Impact factor: 5.157

4.  Regulation of activation and processing of the cystic fibrosis transmembrane conductance regulator (CFTR) by a complex electrostatic interaction between the regulatory domain and cytoplasmic loop 3.

Authors:  Guangyu Wang; Dayue Darrel Duan
Journal:  J Biol Chem       Date:  2012-10-11       Impact factor: 5.157

5.  Role of the juxtamembrane region of cytoplasmic loop 3 in the gating and conductance of the cystic fibrosis transmembrane conductance regulator chloride channel.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  Biochemistry       Date:  2012-05-07       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.